Skip to content

ACE applications are now open through October 15. Join a national network committed to providing high-quality, comprehensive Ataxia care. Apply Now!

The role of the cerebellum in speech production

The role of the cerebellum in speech production

This research aims to characterize the role of the cerebellum in speech motor control. This work will help us understand how the cerebellum works and may lead to the development of new
therapies for speech disorders caused by cerebellar damage.

ClinicalTrials.gov Link: https://uwmadison.co1.qualtrics.com/jfe/form/SV_aW42TaM3tu7OE

Disclaimer: This research opportunity is not affiliated with NAF. We are sharing this information as a resource for the Ataxia community. Sharing this information does not imply endorsement by NAF. 

About the Study

Eligible Ataxia Types
Friedreich’s Ataxia

Type of Study
Research Study

Age Range
18+

Study Start Date
06/01/2026

Estimated Completion Date
05/31/2030

IRB Approval #
19-27146 (UC, San Francisco)

Location(s)

University of Wisconsin-Madison
1500 Highland Ave
Madison, WI 

Contact Information

Chris Naber
speechmotor@waisman.wisc.edu
608-262-5776

Ben Parrell
bparrell@wisc.ed

What does participation in the study entail?

The study takes place over 2 days in Madison, Wisconsin. The experiments involve relatively simple and non-invasive procedures, including a few different speaking, listening, reaching, and rhythm tasks. We will also ask you to complete psychophysical tests and an MRI scan.

What are the potential/risks benefits for participants?

There are minimal risks for participating, primarily associated with the MRI scan. We will screen potential participants to minimize this risk. There are no risks associated with our behavioral experiments. There are no direct benefits to participants, outside of payment for time.

Is there financial compensation?

$20/hr, approximately $200 total.

Is there travel reimbursement?

We pay for all travel expenses

Who is eligible?

For this component of the study, we are recruiting adults with Friedreich’s Ataxia.

View Other Research Opportunities

This research aims to characterize the role of the cerebellum in speech motor control. This work will help us understand how the cerebellum works and may lead to the development of new
therapies for speech disorders caused by cerebellar damage.

ClinicalTrials.gov Link: https://uwmadison.co1.qualtrics.com/jfe/form/SV_aW42TaM3tu7OE

Disclaimer: This research opportunity is not affiliated with NAF. We are sharing this information as a resource for the Ataxia community. Sharing this information does not imply endorsement by NAF. 

About the Study

Eligible Ataxia Types
Friedreich’s Ataxia

Type of Study
Research Study

Age Range
18+

Study Start Date
06/01/2026

Estimated Completion Date
05/31/2030

IRB Approval #
19-27146 (UC, San Francisco)

Location(s)

University of Wisconsin-Madison
1500 Highland Ave
Madison, WI 

Contact Information

Chris Naber
speechmotor@waisman.wisc.edu
608-262-5776

Ben Parrell
bparrell@wisc.ed

What does participation in the study entail?

The study takes place over 2 days in Madison, Wisconsin. The experiments involve relatively simple and non-invasive procedures, including a few different speaking, listening, reaching, and rhythm tasks. We will also ask you to complete psychophysical tests and an MRI scan.

What are the potential/risks benefits for participants?

There are minimal risks for participating, primarily associated with the MRI scan. We will screen potential participants to minimize this risk. There are no risks associated with our behavioral experiments. There are no direct benefits to participants, outside of payment for time.

Is there financial compensation?

$20/hr, approximately $200 total.

Is there travel reimbursement?

We pay for all travel expenses

Who is eligible?

For this component of the study, we are recruiting adults with Friedreich’s Ataxia.

View Other Research Opportunities

Print Friendly, PDF & Email
Translate »

Join the Ataxia community today!

Become a free member for exclusive content from NAF.